Sanaria Inc.
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 19, 2027The maintenance fee for Neutralizing Antibodies to Plasmodium Falciparum Circumsporozoite Protein and Their Use (US 11,760,794) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
- 1 fee due Apr 15, 2027The maintenance fee for Infectious Plasmodium Sporozoites Grown in Vitro (US 10,441,646) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
- 2 fees due Jul 26 to 30, 2027 · next Jul 26
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,749,519 | Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax In force · From the USPTO record | In force | From the USPTO record | |
| US 8,043,625 | Purified plasmodium and vaccine compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,367,810 | Purified plasmodium and vaccine compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,821,896 | Purified Plasmodium and vaccine composition In force · From the USPTO record | In force | From the USPTO record | |
| US 9,241,982 | Purified plasmodium and vaccine compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 9,616,115 | Purified plasmodium and vaccine compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 10,272,146 | Purified Plasmodium and Vaccine Compositions In force · Low confidence | In force | Low confidence | |
| US 8,992,944 | Purified Plasmodium and Vaccine Composition In force · Medium confidence | In force | Medium confidence | |
| US 9,878,026 | Infectious Plasmodium Sporozoites Grown in Vitro In force · Medium confidence | In force | Medium confidence | |
| US 10,441,646 | Infectious Plasmodium Sporozoites Grown in Vitro In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 19: 6 patents in force now held by others · 3 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 3 abandoned · 1 no status recorded